157 related articles for article (PubMed ID: 38792805)
21. Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.
Lu Y; Ren S; Jiang J
BMC Surg; 2023 Jan; 23(1):27. PubMed ID: 36717904
[TBL] [Abstract][Full Text] [Related]
22. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma.
Niu XK; He XF
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143160
[TBL] [Abstract][Full Text] [Related]
23. Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.
Xin Y; Zhang X; Yang Y; Chen Y; Wang Y; Zhou X; Li X
J Gastrointest Oncol; 2021 Dec; 12(6):2930-2942. PubMed ID: 35070419
[TBL] [Abstract][Full Text] [Related]
24. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.
Shuyao W; Mingyang B; Feifei M; Xiaoqin H
J Gastrointest Surg; 2022 Feb; 26(2):341-351. PubMed ID: 34506016
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin.
Xu L; Zhao D; Tian P; Ding J; Jiang Z; Ni G; Hou Z; Ni C
J Hepatocell Carcinoma; 2023; 10():2239-2250. PubMed ID: 38107543
[TBL] [Abstract][Full Text] [Related]
26. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma.
Jiang J; Hu H; Liu R; Wang JH; Long XR; Fan J; Yan ZP
Medicine (Baltimore); 2017 Aug; 96(32):e7390. PubMed ID: 28796032
[TBL] [Abstract][Full Text] [Related]
27. Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience.
Zheng Z; Guan R; Zou Y; Jian Z; Lin Y; Guo R; Jin H
J Inflamm Res; 2022; 15():5089-5102. PubMed ID: 36091335
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
[TBL] [Abstract][Full Text] [Related]
29. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization.
Tu X; Zhang J; Li M; Lu F; Wang T; Gong W; Xiang B
J Hepatocell Carcinoma; 2023; 10():1881-1895. PubMed ID: 37901717
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
[TBL] [Abstract][Full Text] [Related]
32. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
33. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
34. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
35. A novel prognostic nomogram for hepatocellular carcinoma after thermal ablation.
Tao Q; Zeng Q; Liu W; Liu J; Jiang L; Tu X; Li K; Zhao P; Tang X; Liu Z; Wang L; Xu Q; Zheng Y
Am J Cancer Res; 2021; 11(10):5126-5140. PubMed ID: 34765316
[TBL] [Abstract][Full Text] [Related]
36. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
37. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection.
Bai S; Yang P; Wei Y; Wang J; Lu C; Xia Y; Si A; Zhang B; Shen F; Tan Y; Wang K
Front Oncol; 2023; 13():1166327. PubMed ID: 37152055
[TBL] [Abstract][Full Text] [Related]
39. Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study.
Su K; Shen Q; Tong J; Gu T; Xu K; Li H; Chi H; Liu Y; Li X; Wen L; Song Y; Guo Q; Chen J; Wu Z; Jiang Y; He K; Guo L; Han Y
Ann Hepatol; 2023; 28(4):101109. PubMed ID: 37100384
[TBL] [Abstract][Full Text] [Related]
40. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
